Yes, inform your healthcare provider about your celiac disease diagnosis, current dietary adherence, ongoing symptoms, nutritional deficiencies, and other autoimmune conditions
GLP-1 medications like Semaglutide are different from older classes of prescription weight-loss medications because they work on key underlying metabolic pathways to support sustained weight loss
The criteria marked for exclusion are shown below
Essential fatty acids and its rapid growth rate also makes Spirulina a potential source of biodiesel for energy related applications
By activating GLP-1 receptors, semaglutide helps: Stimulate insulin production when blood sugar is high Reduce glucagon secretion, which further lowers blood sugar Slow down digestion, promoting a feeling of fullness Decrease appetite by acting on brain centers controlling hunger The FDA has approved Ozempic for the treatment of type 2 diabetes, while Wegovy, a higher-dose formulation of semaglutide, is specifically approved for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity
Avoid products marketed as compounded semaglutide, compounded tirzepatide, or custom GLP-1 blends